The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs

Hepatic fibrosis is a progressive disease with serious clinical complications that arise from abnormal propagation and activation of multiple inflammatory pathways. Nilotinib is an oral tyrosine kinase inhibitor with antifibrotic activity. Mesenchymal stem cells (MSCs) are blank cells and can differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabil, Ahmed, Uto, Koichiro, Zahran, Faten, Soliman, Reham, Hassan, Ayman A., Elshemy, Mohamed M., Ali, Islam S., Ebara, Mitsuhiro, Shiha, Gamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021473/
https://www.ncbi.nlm.nih.gov/pubmed/33855079
http://dx.doi.org/10.1155/2021/6678913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021473/
https://www.ncbi.nlm.nih.gov/pubmed/33855079
http://dx.doi.org/10.1155/2021/6678913

Ejemplares similares